在初级或二级男性异能症的药理学干预:一个系统的审查
M P Gómez-Bueno1, A M Diaz-Hung1, H A García-Perdomo1
1Grupo de Investigación UROGIV, Escuela de Medicina, Universidad del Valle, Cali, Colombia; Unidad de Urología/Uro-Oncología, Departamento de Cirugía, Escuela de Medicina. Universidad del Valle, Cali, Colombia.
Actas urologicas espanolas
|September 12, 2025
概括
药物治疗方法,如卡伯戈林和约欣宾,在改善异常高潮的男性中表现出有效性. 这些疗法为性功能提供了潜在的好处,但通常观察到轻微的副作用.
科学领域:
- 性医学性医学性医学性医学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 无性高潮症,即难以达到性高潮或无法达到性高潮,会影响有初级或二级疾病的男性.
- 正在探索药理干预措施来解决这种性功能障碍.
研究的目的:
- 评估成年男性 anorgasmia 药物治疗的有效性和安全性.
- 为了评估诱导性高潮的改善,国际勃起功能指数 (IIEF) 和亚利桑那州性经验量表 (ASEX) 得分.
主要方法:
- 根据Cochrane协作和PRISMA指南进行了系统审查.
- 在主要的数据库中进行了搜索,包括MEDLINE,EMBASE,LILACS和CENTRAL.
- 在观察性研究中使用STROBE,在临床试验中使用Rob 2.0,评估了偏差风险.
主要成果:
- 七项研究包括234名患者,其中232人接受药理治疗.
- 卡伯戈林在66%的患者中改善了性高潮;约欣宾在55%.
- 使用卡伯戈林和布罗,IIEF高潮功能的显著改善. 聚烯醇提高了ASEX的分数.
结论:
- 药理疗法,包括卡伯戈林,约欣宾,布洛普和皮克诺根醇,可以积极影响男性的高潮功能.
- 这些治疗方法代表了一种可行的选择,用于管理异常性高潮.
相关概念视频
Male Sexual Response: Erection & Ejaculation
19.2K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
19.2K
Disorders of the Male Reproductive System
4.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
4.0K
Infertility in Males
528
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
528
Antidepressant Drugs: MAOIs and Other Agents
831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
571
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
571
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.4K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.4K

